Highlights Chempartner Pharmatech Co., Ltd.

Equities

300149

CNE100000Y27

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
5.27 ^CNY	+1.74%		+19.23%	-31.11%

Apr. 25	Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 25	Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Tate & Lyle Investments Limited completed the acquisition of Quantum Hi-Tech Biological Co., Ltd. from Chempartner Pharmatech Co., Ltd..	22-06-08	CI
Jiangmen Xinhui Hefeng Trading Co., Ltd. completed the acquisition of Quantum Hi-Tech Health Technology Co., Ltd from Chempartner Pharmatech Co., Ltd..	22-05-04	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Tate & Lyle To Pay $237 Million For Chinese Prebiotic Dietary Fiber Business	22-03-31	MT
Tate & Lyle Investments Limited agreed to acquire Quantum Hi-Tech Biological Co., Ltd. from Chempartner Pharmatech Co., Ltd. for CNY 1500 million.	22-03-30	CI
Porton Pharma Solutions Ltd. agreed to acquire Kaihui Pharmaceutical Co., Ltd. from Chempartner Pharmatech Co., Ltd. for CNY 241 million.	22-03-08	CI
Tranche Update on Chempartner Pharmatech Co., Ltd.'s Equity Buyback Plan announced on January 22, 2021.	22-01-21	CI
Chempartner Pharmatech Co., Ltd.'s Equity Buyback announced on January 22, 2021, has expired with 1,812,900 shares, representing 0.36% for CNY 25.5 million.	22-01-20	CI
Tranche Update on Chempartner Pharmatech Co., Ltd.'s Equity Buyback Plan announced on January 22, 2021.	22-01-05	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Tranche Update on Chempartner Pharmatech Co., Ltd.'s Equity Buyback Plan announced on January 22, 2021.	21-10-12	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Chempartner Pharmatech Co., Ltd.

Equities

300149

CNE100000Y27

Highlights

Filters